Roche Aktie

297,60 EUR +0,40 EUR +0,13 %

09:17:12

STU

277,00 CHF -2,20 CHF -0,79 %

28.05.2025

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.235,44 Mrd. EUR

KGV26,06Div. Rendite3,58%

WKN851311

ISINCH0012032113

SymbolRHHBF

Roche Aktien News

Sortieren:Datum Meistgelesen

28.05.25ZacksTop Analyst Reports for Alphabet, Bank of America & Roche

28.05.25Business TimesSingHealth Duke-NUS’ AI spin-off inks MOUs with Roche, ST Engineering to improve healthcare operations

26.05.25ZacksRoche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer

WerbungRoche-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

26.05.25Financial TimesRoche extends trials of promising antibiotic against resistant superbug

23.05.25ZacksRoche Gets FDA Nod for Label Expansion of Susvimo for Third Indication

23.05.25GlobeNewswireCHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

23.05.25GlobeNewswireRoche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

23.05.25Roche Holding AGRoche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

23.05.25Roche Holding AGNew two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients

23.05.25GlobeNewswireNew two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients

22.05.25GlobeNewswireFDA approves Roche’s Susvimo for diabetic retinopathy

22.05.25Roche Holding AGFDA approves Roche’s Susvimo for diabetic retinopathy

20.05.25Roche Holding AGRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

20.05.25GlobeNewswireRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

14.05.25Roche Holding AGRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis

14.05.25GlobeNewswireRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis

13.05.25Roche Holding AGTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer

13.05.25GlobeNewswireTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer

12.05.25PR NewswireRoche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub

06.05.25Roche Holding AGRoche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity

06.05.25GlobeNewswireRoche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity

01.05.25ZacksRoche Holding AG (RHHBY) is a Great Momentum Stock: Should You Buy?

30.04.25ZacksIs Roche Holding (RHHBY) Stock Outpacing Its Medical Peers This Year?

30.04.25GlobeNewswireCHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings

30.04.25Roche Holding AGCHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings

29.04.25Roche Holding AGRoche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

29.04.25GlobeNewswireRoche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

27.04.25Financial TimesZealand Pharma says obesity drug deal with Roche will help it stay independent

25.04.25Roche Holding AGNew England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission

25.04.25GlobeNewswireNew England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission

24.04.25Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter

24.04.25GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter

23.04.25GlobeNewswireRoche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)

23.04.25Roche Holding AGRoche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)

22.04.25BenzingaRoche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

22.04.25Business TimesRoche to invest US$50 billion in US to avoid Trump tariffs, create 12,000 jobs

22.04.25Financial TimesRoche to spend $50bn on US manufacturing and R&D

22.04.25RTE.ieRoche to invest $50 billion in US to avoid Trump tariffs

22.04.25Roche Holding AGRoche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.